D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 55 Citations 10,499 164 World Ranking 2846 National Ranking 111

Research.com Recognitions

Awards & Achievements

2010 - Member of Academia Europaea

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

His primary scientific interests are in Arthritis, Internal medicine, Immunology, Interleukin 6 and Macrophage activation syndrome. His Arthritis study incorporates themes from Interleukin, Methotrexate, Rheumatoid arthritis and Intensive care medicine. His Internal medicine research integrates issues from Gastroenterology and Endocrinology.

His work in the fields of Immunology, such as Tumor necrosis factor alpha, Perforin and Cellular immunity, overlaps with other areas such as Peripheral blood mononuclear cell. His Interleukin 6 study is focused on Cytokine in general. He combines subjects such as Chemokine, Interferon gamma, CXCL9 and Biologic therapies with his study of Macrophage activation syndrome.

His most cited work include:

  • Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. (553 citations)
  • Interleukin 6 is required for the development of collagen-induced arthritis. (548 citations)
  • Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis. (313 citations)

What are the main themes of his work throughout his whole career to date?

Fabrizio De Benedetti focuses on Internal medicine, Arthritis, Immunology, Rheumatology and Tocilizumab. His study looks at the intersection of Internal medicine and topics like Gastroenterology with Absolute neutrophil count. In the field of Arthritis, his study on Macrophage activation syndrome overlaps with subjects such as In patient.

His is involved in several facets of Immunology study, as is seen by his studies on Interleukin 6, Inflammation, Proinflammatory cytokine, Immune system and Cytokine. His Rheumatology research is multidisciplinary, incorporating elements of MEDLINE, Erythrocyte sedimentation rate, Physical therapy, Etanercept and Pediatrics. The study incorporates disciplines such as Randomized controlled trial and Neutropenia in addition to Tocilizumab.

He most often published in these fields:

  • Internal medicine (54.34%)
  • Arthritis (41.10%)
  • Immunology (35.62%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (54.34%)
  • Arthritis (41.10%)
  • Immunology (35.62%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Arthritis, Immunology, Anakinra and Tocilizumab. His Internal medicine study frequently involves adjacent topics like Gastroenterology. His study of Macrophage activation syndrome is a part of Arthritis.

His research investigates the link between Immunology and topics such as Hemophagocytic lymphohistiocytosis that cross with problems in Ex vivo. Fabrizio De Benedetti has researched Anakinra in several fields, including First episode, Acute pericarditis, Pericarditis and Discontinuation. Fabrizio De Benedetti works mostly in the field of Tocilizumab, limiting it down to concerns involving Randomized controlled trial and, occasionally, Quality of life.

Between 2018 and 2021, his most popular works were:

  • Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis. (313 citations)
  • On the Alert for Cytokine Storm: Immunopathology in COVID-19. (273 citations)
  • Classification criteria for autoinflammatory recurrent fevers (88 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

His primary areas of investigation include Internal medicine, Arthritis, Immunology, Cytokine and Inflammation. Internal medicine and Gastroenterology are commonly linked in his work. His work deals with themes such as Anakinra, Tocilizumab, Disease and Rheumatology, which intersect with Arthritis.

His work on Immune system, Immune dysregulation, Hypogammaglobulinemia and B cell as part of general Immunology study is frequently connected to Adenosine Deaminase 2 Deficiency, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His research integrates issues of Cytopenia, Rash and Cell biology in his study of Inflammation. As a part of the same scientific family, Fabrizio De Benedetti mostly works in the field of Interleukin 18, focusing on Immunopathology and, on occasion, Interleukin 6.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Jurgen Sota;Antonella Insalaco;Rolando Cimaz;Maria Alessio.
Frontiers in Pharmacology (2019)

944 Citations

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Fabrizio De Benedetti;Hermine I. Brunner;Nicolino Ruperto;Andrew Kenwright.
The New England Journal of Medicine (2012)

828 Citations

Interleukin 6 is required for the development of collagen-induced arthritis.

Tonino Alonzi;Elena Fattori;Domenico Lazzaro;Patrizia Costa.
Journal of Experimental Medicine (1998)

756 Citations

2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative

Angelo Ravelli;Francesca Serena Minoia;Sergio Davi;Anna Carin Horne.
Arthritis & Rheumatism (2016)

583 Citations

On the Alert for Cytokine Storm: Immunopathology in COVID-19.

Lauren A Henderson;Scott W Canna;Grant S Schulert;Stefano Volpi.
Arthritis & Rheumatism (2020)

571 Citations

Correlation of Serum Interleukin-6 Levels with Joint Involvement and Thrombocytosis in Systemic Juvenile Rheumatoid Arthritis

Fabrizio de Benedetti;Margherita Massa;Piera Robbioni;Angelo Ravelli.
Arthritis & Rheumatism (1991)

418 Citations

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Angelo Ravelli;Francesca Minoia;Sergio Davì;Annacarin Horne.
Annals of the Rheumatic Diseases (2016)

324 Citations

Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.

Rachelle Donn;Zaynab Alourfi;Fabrizio De Benedetti;Cristina Meazza.
Arthritis & Rheumatism (2002)

319 Citations

Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system.

Fabrizio De Benedetti;Nadia Rucci;Andrea Del Fattore;Barbara Peruzzi.
Arthritis & Rheumatism (2006)

309 Citations

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

Fabrizio De Benedetti;Marco Gattorno;Jordi Anton;Eldad Ben-Chetrit.
The New England Journal of Medicine (2018)

299 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Fabrizio De Benedetti

Alberto Martini

Alberto Martini

University of Genoa

Publications: 91

Angelo Ravelli

Angelo Ravelli

University of Genoa

Publications: 81

Marco Gattorno

Marco Gattorno

Istituto Giannina Gaslini

Publications: 58

Nicolino Ruperto

Nicolino Ruperto

Istituto Giannina Gaslini

Publications: 54

Seza Ozen

Seza Ozen

Hacettepe University

Publications: 51

Rolando Cimaz

Rolando Cimaz

University of Milan

Publications: 40

Richard Bucala

Richard Bucala

Yale University

Publications: 38

Nico M Wulffraat

Nico M Wulffraat

Utrecht University

Publications: 35

Tadamitsu Kishimoto

Tadamitsu Kishimoto

Osaka University

Publications: 33

Berent J. Prakken

Berent J. Prakken

Utrecht University

Publications: 32

Stefan Rose-John

Stefan Rose-John

Kiel University

Publications: 32

Christian M. Hedrich

Christian M. Hedrich

University of Liverpool

Publications: 29

Daniel J. Lovell

Daniel J. Lovell

Cincinnati Children's Hospital Medical Center

Publications: 28

Peter A. Nigrovic

Peter A. Nigrovic

Boston Children's Hospital

Publications: 28

Salvatore Albani

Salvatore Albani

National University of Singapore

Publications: 27

Roberto Giacomelli

Roberto Giacomelli

Sapienza University of Rome

Publications: 25

Trending Scientists

Aristidis Likas

Aristidis Likas

University of Ioannina

Gholam Reza Jahanshahloo

Gholam Reza Jahanshahloo

Kharazmi University

Yuan Liu

Yuan Liu

Hunan University

Huaiwu Zhang

Huaiwu Zhang

University of Electronic Science and Technology of China

Patrick G. Gallagher

Patrick G. Gallagher

Yale University

Sean Sloan

Sean Sloan

James Cook University

Gerard Pals

Gerard Pals

Vrije Universiteit Amsterdam

Maik Hüttemann

Maik Hüttemann

Wayne State University

Tony Ng

Tony Ng

King's College London

Radoje Drmanac

Radoje Drmanac

Complete Genomics

Andrew Nicol

Andrew Nicol

University of Canterbury

Daniel O'Sullivan

Daniel O'Sullivan

University of Leeds

Alan C. Bird

Alan C. Bird

University College London

Michael Stumvoll

Michael Stumvoll

Leipzig University

Pradeep Chhibber

Pradeep Chhibber

University of California, Berkeley

Something went wrong. Please try again later.